A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts. [electronic resource]
Producer: 20011204Description: 234-42 p. digitalISSN:- 0030-2414
- Adenocarcinoma -- drug therapy
- Animals
- Anthraquinones -- therapeutic use
- Antigens, Neoplasm
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Division -- drug effects
- DNA Damage
- DNA Topoisomerases, Type II -- metabolism
- DNA, Neoplasm -- drug effects
- DNA-Binding Proteins
- Doxorubicin -- therapeutic use
- Ethanolamines -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, bcl-2
- Humans
- Intercalating Agents -- pharmacology
- Male
- Mice
- Mice, Nude
- Molecular Structure
- Neoplasm Proteins -- genetics
- Oxidation-Reduction
- Oxidative Stress
- Phosphorylation
- Prostatic Neoplasms -- drug therapy
- Protein Processing, Post-Translational -- drug effects
- Proto-Oncogene Proteins c-bcl-2 -- biosynthesis
- Pyrazoles -- pharmacology
- Pyrazolones
- Remission Induction
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.